Jasper Therapeutics
JSPR
JSPR
60 hedge funds and large institutions have $380M invested in Jasper Therapeutics in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
79.54% more ownership
Funds ownership: 6.92% → 86.46% (+80%)
46% more funds holding
Funds holding: 41 → 60 (+19)
Holders
60
Holding in Top 10
6
Calls
$4.27M
Puts
$855K
Top Buyers
| 1 | +$22.3M | |
| 2 | +$21.2M | |
| 3 | +$15.4M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$12.7M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12M |
Top Sellers
| 1 | -$4.8M | |
| 2 | -$2.23M | |
| 3 | -$1.98M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.76M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$1.09M |